Exchange: NASDAQ·Updated 06:31 PM EST
GRI logo

GRI GRI Bio Inc

$1.12
$0.00
(0.00%)
Today
Closed $1.12
$0.00
(0.00%)
After Hours
Mkt Cap$2.45M
Vol25,097.00

About GRI

GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.
34

Bearish Sentiment

How do you feel about GRI?

Dennygolf
$GRI Analyst estimate's were for a Q3 loss of .84 per share. Actual 10Q reporting was a loss of .69 per share posted Friday 11/13.
1
Robert2500
$GRI GRI Bio Reports $5.1M Nine-Month Loss, Flags Going-Concern Doubt Posted on November 14, 2026 at 10:40 am (GMT+8) GRI Bio noted it has not generated significant revenue from operations since its inception in 2009 and has an accumulated deficit of $56.8 million through September 30, 2026. The company said its ability to continue as a going concern depends on raising additional capital through equity or debt issuances or strategic partnerships, and there can be no assurance such financing will be available on acceptable terms. GRI Bio disclosed that its MVLS is currently less than $5 million. If the requirement becomes effective, a company whose MVLS remains below the threshold for 30 consecutive business days would face immediate suspension from trading and delisting proceedings, with no cure period. The company said such an outcome could further impair its ability to raise capital and its ability to continue as a going concern.
Robert2500
$GRI pump and dump scam… this company has no real followers and investors. It will be gone soon
Robert2500
$GRI lol and down it goes… so nothing from that call at midnight uh? This going down to 1.38 ATL this week

Advertisement|Remove ads.